1. Home
  2. BRNS vs ONDS Comparison

BRNS vs ONDS Comparison

Compare BRNS & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRNS
  • ONDS
  • Stock Information
  • Founded
  • BRNS 2016
  • ONDS 2014
  • Country
  • BRNS United Kingdom
  • ONDS United States
  • Employees
  • BRNS N/A
  • ONDS N/A
  • Industry
  • BRNS Biotechnology: Pharmaceutical Preparations
  • ONDS Telecommunications Equipment
  • Sector
  • BRNS Health Care
  • ONDS Telecommunications
  • Exchange
  • BRNS Nasdaq
  • ONDS Nasdaq
  • Market Cap
  • BRNS 41.0M
  • ONDS N/A
  • IPO Year
  • BRNS 2021
  • ONDS N/A
  • Fundamental
  • Price
  • BRNS $1.11
  • ONDS $1.47
  • Analyst Decision
  • BRNS Strong Buy
  • ONDS Strong Buy
  • Analyst Count
  • BRNS 2
  • ONDS 2
  • Target Price
  • BRNS $4.00
  • ONDS $2.50
  • AVG Volume (30 Days)
  • BRNS 63.4K
  • ONDS 6.2M
  • Earning Date
  • BRNS 11-06-2024
  • ONDS 11-12-2024
  • Dividend Yield
  • BRNS N/A
  • ONDS N/A
  • EPS Growth
  • BRNS N/A
  • ONDS N/A
  • EPS
  • BRNS N/A
  • ONDS N/A
  • Revenue
  • BRNS $14,969,000.00
  • ONDS $8,024,937.00
  • Revenue This Year
  • BRNS $1,805.74
  • ONDS N/A
  • Revenue Next Year
  • BRNS N/A
  • ONDS $255.67
  • P/E Ratio
  • BRNS N/A
  • ONDS N/A
  • Revenue Growth
  • BRNS 106.21
  • ONDS N/A
  • 52 Week Low
  • BRNS $0.80
  • ONDS $0.54
  • 52 Week High
  • BRNS $4.16
  • ONDS $1.99
  • Technical
  • Relative Strength Index (RSI)
  • BRNS 54.91
  • ONDS 65.28
  • Support Level
  • BRNS $0.98
  • ONDS $1.06
  • Resistance Level
  • BRNS $1.25
  • ONDS $1.88
  • Average True Range (ATR)
  • BRNS 0.14
  • ONDS 0.27
  • MACD
  • BRNS 0.03
  • ONDS 0.06
  • Stochastic Oscillator
  • BRNS 68.82
  • ONDS 66.11

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.

Share on Social Networks: